Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Suven Life Sciences Limited
SUVENCurrent price
119.83 INR
-0.67 INR (-0.56%)
Last closed
119.99 INR
Company
www.suven.com
ISIN
INE495B01020
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
National Stock Exchange of India
Capitalization
28 135 317 685 INR
Yield for 12 month
+45.42 %
1Y
3Y
5Y
10Y
15Y
SUVEN
Suven Life Sciences Limited, a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India, the United States, Europe, and internationally. The company engages in drug discovery and development of new chemical entities in central nervous system diseases. Its product candidates include Masupirdine (SUVN-502) for the treatment of Alzheimer disease and neuropsychiatric symptoms; Samelisant (SUVN-G3031), a histamine 3 receptor inverse agonist for the treatment of sleep and cognitive disorders; and Ropanicant (SUVN-911), Alpha4Beta2 nAChRs receptor antagonist for the treatment of depressive disorders. The company is developing Usmarapride (SUVN-D4010), a potent, selective, and orally bio-available and brain penetrant 5-HT4 receptor partial agonist for the treatment of cognitive disorders; SUVN-I6107 for the treatment of cognitive disorders; SUVN-M8036 for the treatment of psychiatric disorders; and SUVN-D1044 for the treatment of gastrointestinal disorders. The company was formerly known as Suven Pharmaceuticals Pvt. Ltd. and changed its name to Suven Life Sciences Limited in 2003. The company was incorporated in 1989 and is headquartered in Hyderabad, India. Suven Life Sciences Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited. Address: 8-2-334, SDE Serene Chambers, Hyderabad, India, 500034
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
23 807.64 INRP/E ratio
–Dividend Yield
–Current Year
+116 980 918 INR
Last Year
+135 452 127 INR
Current Quarter
+25 740 405 INR
Last Quarter
+10 064 444 INR
Current Year
-200 886 208 INR
Last Year
+129 793 664 INR
Current Quarter
-60 816 004 INR
Last Quarter
-71 093 557 INR
Key Figures SUVEN
1 year
3 years
5 years
10 years
EBITDA
-1 597 821 512 INR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-36.7 %
PEG Ratio
–
Return On Equity TTM
-54.98 %
Wall Street Target Price
23 807.64 INR
Revenue TTM
84 186 381 INR
Book Value
8.81 INR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-15.9 %
Dividend Yield
–
Gross Profit TTM
135 452 145 INR
Earnings per share
-6.69 INR
Diluted Eps TTM
-6.69 INR
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
1556.7 %
Profit Margin
–
Dividend Analytics SUVEN
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
22 %Dividend History SUVEN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
14.02.2019
Forward Annual Dividend Yield
–
Last Split Factor
10:5
Payout Ratio
–
Last Split Date
23.03.2007
Dividend Date
–
Stock Valuation SUVEN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
313.3565
Price Sales TTM
335.6021
Enterprise Value EBITDA
-11.7118
Price Book MRQ
14.5959
Financials SUVEN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators SUVEN
For 52 weeks
74.53 INR
169.38 INR
50 Day MA
139.01 INR
Shares Short Prior Month
–
200 Day MA
120 INR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart